释义 |
Aggrenox 基本例句 是一种抗中风药阿司匹林和缓释双嘧达莫制剂 Results Compared to the imported reference preparationAggrenox, it was no significant difference in bioavailability.结果 自制制剂与国外参比制剂相比生物利用度无显著差异。 A total of 83 percent of the patients receied extended-release dipyridamole, and up to 8 percent receied the fixed-dose combination twice daily, which is marketed asAggrenoxor Asasantin.全部的83名病人接受了额外的双嘧达莫治疗,有总共8%的病人每天两次接受固定剂量的联合疗法,就想市场上销售的Aggrenox和Asasantin。 |